Immediate and long term effects of weight reduction in obese people with asthma:: randomised controlled study

被引:390
作者
Stenius-Aarniala, B
Poussa, T
Kvarnström, J
Grönlund, EL
Ylikahri, M
Mustajoki, P
机构
[1] Univ Helsinki, Cent Hosp, Dept Med, Div Pulm Med & Allergol, FIN-00029 Hyks, Finland
[2] STAT Consulting, FIN-33540 Tampere, Finland
[3] Peijas Hosp, FIN-01400 Vantaa, Finland
关键词
D O I
10.1136/bmj.320.7238.827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To investigate the influence of weight reduction on obese patients with asthma. Design Open study two randomised parallel groups. Setting Private outpatients centre, Helsinki, Finland. Participants Two groups of 19 obese patients with asthma (body mass index (kg/m(2)) 30 to 42) recruited through newspaper advertisements. Intervention Supervised weight reduction programme including 8 week very low energy diet. Main outcome measures Body weight morning peak expiratory flow (PEF), forced vital capacity (FVC), forced expiratory volume in one second (FEV1); and also asthma symptoms, number of acute episodes, courses of oral steroids, health status (quality of life). Results At the end of the weight reducing programme, the participants in the treatment group had lost a mean of 14.5% of their pretreatment weight, the controls 0.3%. The corresponding figures after one) ear were 11.3% and a weight gain of 2.2%. After the 8 week dieting period the difference in changes in percentage of predicted FEV1 from baseline in the treatment and control groups was 7.2% (95% confidence interval 1.9% to 12.5%, P = 0.009). The corresponding difference in the changes in FVC was 8.6% (4.8% to 12.5%, P < 0.0001). After one lear the differences in the changes in the two groups were still significant: 7.6% for FEV1 (1.5% to 13.8%, P = 0.02) and 7.6% for FVC (3.5% to 11.8%, P = 0.001). By the end of the weight reduction programme, reduction in dyspnoea was 13 mm (on a visual analogue scale 0 mm to 100 mm) in the treatment group and 1 mm in the control group (P = 0.02). The reduction of rescue medication was 1.2 and 0.1 doses respectively (P = 0.03). After one year the differences in the changes between the two groups were - 12 for symptom scores (range - 1 to - 22, P = 0.04) and - 10 for total scores (- 18 to - 1, P = 0.02). The median number of exacerbations in the treatment group was 1 (0-4) and in the controls 4 (0-7), P = 0.001. Conclusion Weight reduction in obese patients with asthma improves lung function, symptoms, morbidity and health status.
引用
收藏
页码:827 / 832
页数:6
相关论文
共 16 条
[1]   EFFECT OF ALTERATIONS OF DIETARY-SODIUM ON THE SEVERITY OF ASTHMA IN MEN [J].
CAREY, OJ ;
LOCKE, C ;
COOKSON, JB .
THORAX, 1993, 48 (07) :714-718
[2]  
GALL H, 1990, ALLERGOLOGIE, V13, P352
[3]   The treatment and prevention of obesity: A systematic review of the literature [J].
Glenny, AM ;
OMeara, S ;
Melville, A ;
Sheldon, TA ;
Wilson, C .
INTERNATIONAL JOURNAL OF OBESITY, 1997, 21 (09) :715-737
[4]  
HAKALA K, 1995, INT J OBESITY, V19, P343
[5]   The role of gastroesophageal reflux in chronic cough and asthma [J].
Harding, SM ;
Richter, JE .
CHEST, 1997, 111 (05) :1389-1402
[6]   Investigation of the effect of short-term change in dietary magnesium intake in asthma [J].
Hill, J ;
Micklewright, A ;
Lewis, S ;
Britton, J .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (10) :2225-2229
[7]   QUALITY-OF-LIFE, SYMPTOMS AND PULMONARY-FUNCTION IN ASTHMA - LONG-TERM TREATMENT WITH NEDOCROMIL SODIUM EXAMINED IN A CONTROLLED MULTICENTER TRIAL [J].
JONES, PW .
EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (01) :55-62
[8]  
MUSTAJOKI P, 1998, DIS MANAGEMENT HLTH, V4, P267
[9]  
NUNN JA, 1989, BRIT MED J, V289, P1068
[10]  
Pekkarinen T, 1996, INT J OBESITY, V20, P332